The COVID-19 pandemic was a calamity in more ways than one: lost lives, shuttered businesses, closed borders, broken supply chains, joblessness, and frayed social unity.
In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Michael Ibara, chief data officer at Elligo Health Research, discussing AI in clinical research and its overall impact on
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.